Johan Jeong Selected Research

PF-9366

5/2020

MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johan Jeong Research Topics

Disease

5	Leukemia 05/2020 - 10/2015
2	Neoplasms (Cancer) 05/2020 - 01/2018
2	Genetic Translocation (Chromosomal Translocation) 10/2019 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2018 - 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2018

Drug/Important Bio-Agent (IBA)

1	Methionine AdenosyltransferaseIBA 05/2020
1	S-Adenosylmethionine (Ademetionine)IBA 05/2020
1	PF-9366IBA 05/2020
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Dasatinib (BMS 354825)FDA Link 11/2018
1	Tyrosine Kinase InhibitorsIBA 11/2018
1	Transcription Activator-Like Effector NucleasesIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	Histone-Lysine N-MethyltransferaseIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018

Therapy/Procedure

3	Transplantation 10/2019 - 10/2015
2	Therapeutics 10/2019 - 01/2018